Clinical trial
A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients.
NCT00077766 · Hoffmann-La Roche, Industry · Completed
Key facts
| NCT number | NCT00077766 |
|---|---|
| Title | A Study of Intravenous Mircera for the Treatment of Anemia in Dialysis Patients. |
| Official title | A Randomized, Controlled, Open-label, Multi-center, Parallel-group Study to Demonstrate the Efficacy and Safety of RO0503821 When Administered Intravenously for the Maintenance Treatment of Anemia in Patients With Chronic Kidney Disease Who Are on Dialysis. |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Anemia |
| Intervention type | Drug |
| Interventions | Darbepoetin alfa, methoxy polyethylene glycol-epoetin beta [Mircera] |
| Enrollment | 313 |
| Start date | Mar 1, 2004 |
| Primary completion | Aug 1, 2005 |
| Completion | Aug 1, 2005 |
| First posted | Feb 16, 2004 |
| Last update posted | Oct 26, 2016 |
| Countries | Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Spain, Sweden, Switzerland |
At a glance
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: